Nahdi Medical Company (4164.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Nahdi Medical Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 14.87x | 18.63x | 19.95x | 25.13x | 24.00x | 22.97x |
| P/B Ratio | 4.50x | 5.91x | 7.23x | 9.94x | 12.16x | 9.38x |
| P/S Ratio | 1.21x | 1.62x | 2.04x | 2.59x | 2.42x | 2.26x |
| Profitability | ||||||
| Gross Margin | 37.3% | 37.4% | 39.4% | 40.9% | 41.0% | 33.3% |
| Operating Margin | 8.9% | 9.2% | 11.0% | 11.6% | 11.4% | 11.1% |
| Net Margin | 8.1% | 8.7% | 10.2% | 10.3% | 10.1% | 9.8% |
| EBITDA Margin | 16.5% | 17.1% | 18.9% | 18.4% | 18.7% | 17.0% |
| Liquidity | ||||||
| Current Ratio | 1.54x | 1.55x | 1.69x | 1.70x | 1.40x | 1.72x |
| Quick Ratio | 0.46x | 0.70x | 0.83x | 0.92x | 0.53x | 0.85x |
| Leverage | ||||||
| Debt/Equity | 0.65x | 0.59x | 0.48x | 0.52x | 0.85x | 0.59x |
YoY = year-over-year change. Source: FMP..